Key facts
- ShiraTronics, Inc. issued a correction for a previous news release.
- The correction pertains to the RELIEV-CM2 pivotal trial of implantable extracranial neuromodulation systems for chronic migraine.
- The original news release was issued on 02-Jun-2026.
ShiraTronics, Inc. has issued a correction concerning its news release dated June 2, 2026, titled 'ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine.' The company stated that changes have been made to the original announcement, but did not specify the nature of these changes in the provided text.